Tuesday, March 16, 2010

Medical News

Medical News


Poor asthma control increases risk for depression

Posted: 16 Mar 2010 05:00 PM PDT

Asthma patients who believe they have poor control over their condition are more likely to develop depression than those who think they have good asthma control, US research shows.

Add-on montelukast may protect asthmatics against excessive airway narrowing

Posted: 16 Mar 2010 05:00 PM PDT

Asthma patients taking inhaled corticosteroids may benefit from add-on therapy with the leukotriene receptor antagonist montelukast to protect against excessive airway narrowing, say researchers.

Good doctor–patient communication key to good asthma management

Posted: 16 Mar 2010 05:00 PM PDT

Changing an asthma patient's inhaler device without their consent can damage the doctor–patient relationship and may even result in poorer asthma control, UK researchers warn.

Parental bipolar disorder increases child’s psychopathology risk

Posted: 16 Mar 2010 05:00 PM PDT

The risk for attention-deficit hyperactivity disorder and subthreshold manic and depressive symptoms is increased in preschool children of parents with bipolar disorder, the results of a US study indicate.

Novel mania scale allows diagnosis by non-professionals

Posted: 16 Mar 2010 05:00 PM PDT

A novel mania rating scales allows non-professionals in regular contact with a patient to diagnose a manic/mixed episode, say researchers who suggest the scale will complement current rating scales.

Factors involved in GI symptom persistence identified in primary care

Posted: 16 Mar 2010 05:00 PM PDT

Five factors measured during a primary care consultation for gastrointestinal symptoms can predict those patients who will have persistent symptoms, UK researchers report.

Extended use of dual antiplatet therapy after stent implantation questioned

Posted: 15 Mar 2010 05:00 PM PDT

Extending the duration of dual antiplatelet therapy for more than 12 months after receipt of drug-eluting stents in patients with no prior bleeding does not appear to be more effective than aspirin monotherapy for reducing the rate of myocardial infarction or cardiovascular death, researchers report.

EXPLORE-Xa: Betrixaban bleeding outcomes comparable to warfarin in dose-finding trial

Posted: 15 Mar 2010 05:00 PM PDT

The investigational anticoagulant betrixaban has a comparable safety profile to that of warfarin in patients with non-valvular atrial fibrillation or flutter, according to the results of EXPLORE-Xa trial.

EXPLORE-Xa: Betrixaban bleeding outcomes comparable to warfarin in dose-finding trial

Posted: 15 Mar 2010 05:00 PM PDT

The investigational anticoagulant betrixaban has a comparable safety profile to that of warfarin in patients with non-valvular atrial fibrillation or flutter, according to the results of EXPLORE-Xa trial.

Great demand for new markers to improve prostate cancer diagnosis

Posted: 15 Mar 2010 05:00 PM PDT

There is a great demand for new markers to improve prostate cancer diagnosis and prevent unnecessary prostate biopsies, especially in men with a serum prostate-specific antigen of 4–10 ng/ml, say researchers.

Better communication may improve understanding of genomic test results

Posted: 15 Mar 2010 05:00 PM PDT

US researchers report that a significant number of women do not fully understand discussions about their genomic-based recurrence risk for breast cancer.

Mipomersen effective therapy for reducing LDL cholesterol in FH patients

Posted: 15 Mar 2010 05:00 PM PDT

Treatment with the antisense inhibitor of apolipoprotein B synthesis mipomersen is a novel and effective way of reducing low-density lipoprotein cholesterol in patients with homozygous familial hypercholesterolemia, say researchers.

Adipocytes play key role in HDL hemostasis in vivo

Posted: 15 Mar 2010 05:00 PM PDT

Researchers have shown, for the first time, that adipose tissue plays a role in maintaining levels of high-density lipoprotein cholesterol, acting through the ATP-binding cassette subfamily A member 1 and scavenger receptor class B type I cholesterol transporters.

Dapagliflozin improves glycemic control and weight of Type 2 diabetics

Posted: 15 Mar 2010 05:00 PM PDT

Study results show that dapagliflozin treatment improves the glycemic control and body weight of both early and late-stage Type 2 diabetics.

Extended use of dual antiplatet therapy after stent implantation questioned

Posted: 15 Mar 2010 05:00 PM PDT

Extending the duration of dual antiplatelet therapy for more than 12 months after receipt of drug-eluting stents in patients with no prior bleeding does not appear to be more effective than aspirin monotherapy for reducing the rate of myocardial infarction or cardiovascular death, researchers report.

CABANA: pilot study finds catheter ablation more effective than antiarrhythmics

Posted: 15 Mar 2010 05:00 PM PDT

Findings from a small pilot study show that catheter ablation is more effective than antiarrhythmic drug therapy for preventing recurrence of symptomatic atrial fibrillation in problematic patients with substantial underlying cardiovascular disease.

RACE II: Lenient heart rate control in AF not inferior to strict control

Posted: 15 Mar 2010 05:00 PM PDT

Less rigorous control of heart rate in patients with permanent atrial fibrillation appears to be as effective as strict rate control at preventing serious adverse events, including death from all causes, reported investigators from the RACE II study.

Diuretic plus CCB linked to higher MI risk than other combinations

Posted: 04 Feb 2010 04:00 PM PST

A case–control study in low-risk patients with hypertension suggests that treatment with a combination of diuretics and calcium channel blockers may be associated with an increased risk for myocardial infarction compared with other commonly used antihypertensive combination regimens including diuretics.

No comments:

Post a Comment